经鼻高流量氧疗和无创通气在慢性阻塞性肺疾病合并呼吸衰竭中的比较

经鼻高流量氧疗和无创通气在慢性阻塞性肺疾病合并呼吸衰竭中的比较

ID:23523681

大小:561.17 KB

页数:54页

时间:2018-11-08

经鼻高流量氧疗和无创通气在慢性阻塞性肺疾病合并呼吸衰竭中的比较_第1页
经鼻高流量氧疗和无创通气在慢性阻塞性肺疾病合并呼吸衰竭中的比较_第2页
经鼻高流量氧疗和无创通气在慢性阻塞性肺疾病合并呼吸衰竭中的比较_第3页
经鼻高流量氧疗和无创通气在慢性阻塞性肺疾病合并呼吸衰竭中的比较_第4页
经鼻高流量氧疗和无创通气在慢性阻塞性肺疾病合并呼吸衰竭中的比较_第5页
资源描述:

《经鼻高流量氧疗和无创通气在慢性阻塞性肺疾病合并呼吸衰竭中的比较》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库

1、授予单位代码10089学号或申请号16106中国图书分类号R563HebeiMedicalUniversity硕士学位论文学术学位经鼻高流量氧疗和无创通气在慢性阻塞性肺疾病合并呼吸衰竭中的比较研究生:刘晶导师:崔朝勃教授专业:内科学二级学院:衡水市哈励逊国际和平医院2018年3月目录中文摘要················································································1英文摘要·································································

2、···············3英文缩写················································································6研究论文经鼻高流量氧疗和无创通气在慢性阻塞性肺疾病合并呼吸衰竭中的比较前言················································································7材料与方法······································································10

3、结果···············································································13附图···············································································15附表···············································································16讨论·············································

4、··································19结论···············································································22参考文献·········································································22综述经鼻高流量吸氧的临床应用研究进展·····································36致谢·······································

5、··············································50个人简历···············································································51经鼻高流量氧疗和无创通气在慢性阻塞性肺疾病合并呼吸衰竭中的比较摘要目的:慢性阻塞性肺疾病急性加重(AcuteExacerbationofChronicObstructivePulmonaryDisease,AECOPD)是临床上常见的一种疾病类型,对于COPD的治疗,临床上除了常规的基础治疗外,还应积极给予辅助通气改善患者的

6、氧合、减轻二氧化碳潴留,纠正呼吸衰竭症状。本研究拟通过对比经鼻高流量氧疗(highflownasalcannula,HFNC)与无创正压通气(non-invasivepositivepressureventilation,NIPPV)在AECOPD合并II型呼吸衰竭患者中的应用效果,分析其对AECOPD合并II型呼吸衰竭的临床应用价值,旨在为临床上AECOPD合并II型呼吸衰竭的治疗提供可靠的理论依据及数据支持。方法:根据2015年版《慢性阻塞性肺病防治倡议》(GOLD指南)要求,选取2016年12月至2018年1月期间来哈励逊国际和平医院呼吸科住院治疗的AECOPD合并II型呼吸衰竭

7、的患者共268名作为研究对象,符合入选标准及排除标准的患者共105名,经逐一筛选最终共有75名患者纳入本研究,均签署知情同意书,记录其性别、年龄等一般情况。采用随机数字表法将分析对象划分为经鼻高流量组(HFNC组,38例)和无创通气组(NIPPV组,37例)。HFNC组在常规治疗的基础上给予经鼻高流量治疗,NIPPV组患者在常规治疗的基础上给予无创正压通气治疗,最后通过比较两组患者治疗前、治疗后2小时、治疗后6小时、治疗后12小时及治疗后24小

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。